Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 273, Issue 5 36-5, 1997, Pages

  Lee, Kwan S ^a,b   Cottam, Howard B ^c   Houglum, Karl ^a   Bruce Wasson, D ^c   Carson, Dennis ^c   Chojkier, Mario ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c San Diego   (United States)

Author keywords

C myb expression; CREB phosphorylation; Liver fibrogenesis

Indexed keywords

ALPHA ACTIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; DRUG METABOLITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PENTOXIFYLLINE; PHOSPHODIESTERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME INHIBITION; LIVER CELL; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; ONCOGENE C MYB; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RAT; STELLATE CELL;

EID: 0030701875     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1997.273.5.g1094     Document Type: Article

References (10)

1. Badiani, P., P. Corbella, D. Kioussis, J. Marvel, and K. Weston. Dominant interfering alleles define a role for c-myb in T-cell development. Genes Dev. 8: 770-782, 1994.
2. Becker, B. F., N. Reinholz, B. Leipert, P. Raschke, B. Permanetter, and E. Gerlach. Role of uric acid as an endogenous radical scavenger and antioxidant. Chest 100: 176S-181S, 1991.
3. 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury. A link to tissue fibrosis? Hepatology 19: 1262-1271, 1994.
4. Berman, B., J. Weitzerbin, J. Sanceau, G. Merlin, and M. R. Duncan. Pentoxifylline inhibits certain constitutive and tumor necrosis factor-α-induced activities of human normal dermal fibroblasts. J. Invest. Dermatol. 98: 706-712, 1992.
5. Biswas, D. K., C. M. Ahlers, B. J. Dezube, and A. B. Pardee. Cooperative inhibition of NF-kB and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat. Proc. Natl. Acad. Sci. USA 90: 11044-11048, 1993.
6. Blank, R. S., T. C. McQuinn, K. C. Yin, M. M. Thompson, K. Takeyasu, R. J. Schwartz, and G. K. Owens. Elements of the smooth muscle α-actin promoter required in cis for transcriptional activation in smooth muscle. J. Biol. Chem. 267: 984-988, 1992.
7. Buck, M., and M. Chojkier. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 15: 1753-1765, 1996.
8. Buck, M., H. Turler, and M. Chojkier. LAP, a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO J. 13: 851-860, 1994.
9. Chojkier, M. Regulation of collagen gene expression. In: Liver Growth and Regeneration, edited by A. Strain and A. Diehl. London: Chapman & Hall, 1997, p. 430-450.
10. Chojkier, M., and J. Fierer. D-Galactosamine hepatotoxicity is associated with endotoxin-sensitivity and mediated by lymphoreticular cells in mice. Gastroenterology 88: 115-121, 1985.